Last reviewed · How we verify

Adverse Reactions of Enbrel subcutaneously

ASIS Corporation · Phase 1 active Small molecule

Adverse Reactions of Enbrel subcutaneously is a TNF-alpha inhibitor Small molecule drug developed by ASIS Corporation. It is currently in Phase 1 development for Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis. Also known as: Enbrel (etanercept).

Tumor necrosis factor-alpha inhibitor

Tumor necrosis factor-alpha inhibitor Used for Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis.

At a glance

Generic nameAdverse Reactions of Enbrel subcutaneously
Also known asEnbrel (etanercept)
SponsorASIS Corporation
Drug classTNF-alpha inhibitor
TargetTNF-alpha
ModalitySmall molecule
Therapeutic areaImmunology
PhasePhase 1

Mechanism of action

Enbrel works by inhibiting the action of tumor necrosis factor-alpha (TNF-alpha), a substance in the body that causes inflammation and is involved in autoimmune diseases.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Adverse Reactions of Enbrel subcutaneously

What is Adverse Reactions of Enbrel subcutaneously?

Adverse Reactions of Enbrel subcutaneously is a TNF-alpha inhibitor drug developed by ASIS Corporation, indicated for Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis.

How does Adverse Reactions of Enbrel subcutaneously work?

Tumor necrosis factor-alpha inhibitor

What is Adverse Reactions of Enbrel subcutaneously used for?

Adverse Reactions of Enbrel subcutaneously is indicated for Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis.

Who makes Adverse Reactions of Enbrel subcutaneously?

Adverse Reactions of Enbrel subcutaneously is developed by ASIS Corporation (see full ASIS Corporation pipeline at /company/asis-corporation).

Is Adverse Reactions of Enbrel subcutaneously also known as anything else?

Adverse Reactions of Enbrel subcutaneously is also known as Enbrel (etanercept).

What drug class is Adverse Reactions of Enbrel subcutaneously in?

Adverse Reactions of Enbrel subcutaneously belongs to the TNF-alpha inhibitor class. See all TNF-alpha inhibitor drugs at /class/tnf-alpha-inhibitor.

What development phase is Adverse Reactions of Enbrel subcutaneously in?

Adverse Reactions of Enbrel subcutaneously is in Phase 1.

What are the side effects of Adverse Reactions of Enbrel subcutaneously?

Common side effects of Adverse Reactions of Enbrel subcutaneously include Injection site reaction, Headache, Fatigue.

What does Adverse Reactions of Enbrel subcutaneously target?

Adverse Reactions of Enbrel subcutaneously targets TNF-alpha and is a TNF-alpha inhibitor.

Related